The present application claims the priority of Chinese Patent No. 202010021982.8 filed on Jan. 9, 2020 with National Intellectual Property Administration, PRC, titled “STRUCTURALLY FITTED TRANSCATHETER AORTIC VALVE IMPLANTATION DEVICE”, which is incorporated herein by reference in its entirety.
The present disclosure relates to the field of medical devices, and in particular, to a structurally fitted transcatheter aortic valve implantation device that is implantable via an approach through the aorta or through a transapical approach.
About 300 thousand people worldwide are affected by cardiac valve diseases each year. Such diseases involve abnormal leaflet tissues, e.g., excess tissue growth, tissue degeneration or rupture, tissue hardening or calcifying, or abnormal tissue position throughout the cardiac cycle (i.e., annular dilation or ventricular reshaping), leading to dysfunction of valve, e.g., leakage or blood backflow (i.e., valve insufficiency) or resistance to forward blood flow (i.e., valve stenosis).
At present, existing transcatheter aortic valves rely on the inherent properties of the stent material and are simply secured at the position of the original aortic valve by friction. For example, Patent No. CN107890382A discloses a locatable and retrievable transcatheter aortic valve, wherein a first funnel opening structure of a valve stent is in contact with the left ventricular outflow tract and aortic annulus to serve as a support, and the valve stent has a locating rod structure configured for axial locating by securing the valve stent via friction between the lower part of the valve stent and surrounding tissue. However, due to the complexity of the pathological structures, the valve stent is positioned and secured by friction only, which may cause the valve to be pulled and pressed by the original structure after implantation and may cause valve migration, resulting in the risks of embolization, falling off or ejection, thereby causing failure of the valve implantation operation.
The invention therefore intends to provide a transcatheter aortic valve implantation device that is not solely fixed by friction. It forms structural matched with the blood vessels via a special design, accurately releases the valve at the aortic annulus, and avoids the adverse events caused by the existing fixation by friction alone, thus curing the aortic valve diseases. The invention is implemented by the following technical solutions:
The invention provides a structurally fitted transcatheter aortic valve implantation device comprising a valve stent, valve leaflets, an inner skirt and an outer skirt, wherein the valve stent is radially compressible and re-expandable so as to be implanted via a catheter device, and the valve stent comprises a tubular body having a circumference extending along a longitudinal axis; a first longitudinal end portion facing, in an implanted state, the ascending aorta side of the native aortic valve; a second longitudinal end portion facing, in an implanted state, the ventricular side of the native aortic valve; and an intermediate portion connecting the first and second longitudinal end portions with each other, wherein the tubular body has an inner circumferential surface defining an inner cavity of the tubular body and an outer circumferential surface defining an outer surface of the tubular body, the inner and outer circumferential surfaces at least extending substantially concentrically with the longitudinal axis; the first and second longitudinal end portions and the intermediate portion of the tubular body are made of a grid-like structure, a plurality of support arms are provided on the intermediate portion of the tubular body, the support arms being spaced from each other around the circumference of the tubular body, and the support arms formed directly on the tubular body and without being connected to the tubular body by welding or other mechanical means of connection; the valve leaflets are fixed on the intermediate portion of the inner cavity of the tubular body, the inner skirt is fixed at the second longitudinal end portion of the inner cavity of the tubular body and fixedly connected to the valve leaflets, the outer skirt is fixed at the second longitudinal end portion of the outer cavity of the tubular body and fixedly connected to the inner skirt, and the support arms are formed integrally, and are “D”-shaped and fixed between a narrowest part of the aorta close to the heart and a narrowest part above the aortic annulus after complete expansion, such that the outer surfaces of the support arms sufficiently match surrounding tissues; each of the support arms comprises a platform portion, an upper support arm and a lower support arm, the upper and lower support arms being formed tangentially and having smooth transition, and the platform portion being parallel with blood flow and capable of contacting the anatomical structures in the transition regions of the blood vessels and valve in a parallel manner and minimizing the effect on blood flow.
According to the aortic valve implantation device disclosed herein, when the implantation procedure is completed via transaortic or transapical approach, the support arms are expanded horizontally at the aortic annulus, move the tubule toward the ascending aorta to above the aortic annulus under a compressive force in an expanded state, and are fixed at the narrowest part of the aorta close to the heart.
According to the aortic valve implantation device disclosed herein, the upper support arm, the lower support arm and the platform portion each comprises a landing area configured for acquiring a greater tension and/or compression when matched the heart and/or vessels.
According to the aortic valve implantation device disclosed herein, among the three landing areas are provided two bending sections having the same length and a smaller width than the width of the landing areas, such that the support arms are more easily bent to form a “D”-shaped configuration. According to the aortic valve implantation device disclosed herein, the three landing areas of the support arms have equal maximum widths.
According to the aortic valve implantation device disclosed herein, the support arms are distributed equidistantly or non-equidistantly around the circumference of the tubular body.
According to the aortic valve implantation device disclosed herein, the connections between the support arms and the tubular body taper from the landing areas to the bottoms. According to the aortic valve implantation device disclosed herein, the bending sections taper from the landing areas to middle portions.
According to the aortic valve implantation device disclosed herein, the tubular body and the support arms are machined by laser cutting.
According to the aortic valve implantation disclosed herein, the tubular body comprises a plurality of grid nodes, connections among the grid nodes are grid elements, in the intermediate portion the grid nodes are divided into a first node, a second node and a third node according to positions along the axis of the tubular body, two ends of each of the support arms are connected to the first node and the second node respectively, the third node is located between the first node and the second node, and the grid elements between the first nodes and the second nodes to which the support arms are attached have a length greater than that of the grid elements between the first nodes and the second nodes to which the support arms are not attached.
According to the aortic valve implantation device disclosed herein, a minimum width between the support arms and the adjacent grid elements can receive passage of only one laser beam during laser cutting, thereby maximizing the landing area of the support arms.
It should be noted that the dimensions and/or sizes used herein for describing the valve stent generally refer to a free expanded state of the valve stent, i.e., the expanded state other than any compressed circumstance. Thus, the dimensions and/or locations in a re-expanded implanted state may be different due to the compression provided by surrounding tissues.
The present disclosure has advantages that structural matched of the aortic valve implantation device in the operation process is realized through the support arm structure located on the intermediate portion of the stent tubular body, thus reducing the risks of falling off, displacement or ejection in the process of implantation and increasing the success rate of valve implantation.
The present disclosure will be further illustrated with reference to the following specific examples. It should be understood that these examples are merely intended to illustrate the present disclosure rather than limit the protection scope of the present disclosure. In addition, it should be understood that various changes or modifications may be made by those skilled in the art after reading the teachings of present disclosure, and these equivalents also fall within the protection scope of the present disclosure.
As shown in
The implanted valve stent 100 is movable in its expanded state in the direction towards the aortic side 16, with the support arms 50 protruding toward the outer surface 91 of the tubular body 105. Thereby the support arms 50 move longitudinally over the native aortic annulus 70 under its radial compression. As the support arms 50 have a specific profile and are free of hooks, barbs, kinks, etc., the support arms 50 do not become entangled with the body's native tissues or cause tissue damage when moving longitudinally.
Referring to
As shown in
As shown in
Referring to
and the grid elements between the first nodes 61 and the second nodes 62 to which the support arms are attached has a length greater than that of the grid elements between the first nodes 61 and the second nodes 62 to which the support arms are not attached. The process design allows an easier natural bending of the support arms 50 to a “D” shaped configuration when the valve stent 100 expands.
Also, a minimum width between the support arms 50 and the adjacent grid elements can receive passage of only one laser beam during laser cutting, thereby maximizing the landing area 54 of the support arms 50. A larger landing area 54 ensures a larger contact area with the anatomical structures in the transition region of the vessel and valve, enabling a desired distribution of tension and facilitating the structural matched.
The support arms 50 is such designed that the maximum widths of the three landing areas 54 are equal, which allows an easier natural bending of the support arm to a “D” shaped configuration when the valve stent 100 expends.
In the grid structure of the tubular body, different widths of the structures are designed at different grid nodes according to different radial forces.
Examples of the present disclosure have been described above. However, the present disclosure is not limited to the above examples. Any modification, equivalent, improvement and the like made without departing from the spirit and principle of the present disclosure shall fall within the protection scope of the present disclosure.
Number | Date | Country | Kind |
---|---|---|---|
202010021982.8 | Jan 2020 | CN | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/CN2020/121635 | 10/16/2020 | WO |